-
Founded in:
1989-08-29 -
Country:
China -
Address:
No. 22, Minhang South Road, Xiaodian District, Taiyuan City -
Tax NO.:
911401051100866506 -
Registered Funds:
11.56938626 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Chlorzoxazone |
Centrally acting muscle relaxants that act on multiple synaptic pathways in the central nervous system to produce muscle relaxants
More
Centrally acting muscle relaxants that act on multiple synaptic pathways in the central nervous system to produce muscle relaxants |
125mg | 95-25-0 | 19 |
| Acetaminophen |
Centrally acting muscle relaxants act on multiple synaptic pathways in the central nervous system to produce muscle relaxant effects.
More
Centrally acting muscle relaxants act on multiple synaptic pathways in the central nervous system to produce muscle relaxant effects. |
150mg | 103-90-2 | 68 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Indometacin |
This product has anti-inflammatory, antipyretic and analgesic effects. Its mechanism of action is to reduce the synthesis of prostaglandins by inhibiting cyclooxygenase. It stops the formation of pain nerve impulses in inflammatory tissues and inhibits inflammatory reactions, including inhibiting the chemotaxis of leukocytes and the release of lysosomal enzymes. As for the antipyretic effect, it acts on the hypothalamic temperature regulation center, causing peripheral vasodilation and sweating, which increases heat dissipation. This central antipyretic effect may also be related to the inhibition of prostaglandin synthesis in the hypothalamus.
More
This product has anti-inflammatory, antipyretic and analgesic effects. Its mechanism of action is to reduce the synthesis of prostaglandins by inhibiting cyclooxygenase. It stops the formation of pain nerve impulses in inflammatory tissues and inhibits inflammatory reactions, including inhibiting the chemotaxis of leukocytes and the release of lysosomal enzymes. As for the antipyretic effect, it acts on the hypothalamic temperature regulation center, causing peripheral vasodilation and sweating, which increases heat dissipation. This central antipyretic effect may also be related to the inhibition of prostaglandin synthesis in the hypothalamus. |
53-86-1 | 23 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Aluminum hydroxide |
Antacids, which neutralize stomach acid and protect the ulcer surface
More
Antacids, which neutralize stomach acid and protect the ulcer surface |
140mg | 21645-51-2 | 14 |
| Vitamin U (iodomethylmethionine) |
Promote granulation development and mucosal regeneration
More
Promote granulation development and mucosal regeneration |
50mg | 0 | |
| Atropa Belladonnal |
Inhibit glandular secretion and relieve pain caused by smooth spasm
More
Inhibit glandular secretion and relieve pain caused by smooth spasm |
10mg | 0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Captopril |
This product is a competitive angiotensin converting enzyme inhibitor, which prevents angiotensin I from being converted into angiotensin II, thereby reducing peripheral vascular resistance and reducing water and sodium retention by inhibiting aldosterone secretion. This product can also dilate peripheral blood vessels by interfering with the degradation of bradykinin. For patients with heart failure, this product can also reduce capillary wedge pressure and pulmonary vascular resistance, increase cardiac output and exercise tolerance time.
More
This product is a competitive angiotensin converting enzyme inhibitor, which prevents angiotensin I from being converted into angiotensin II, thereby reducing peripheral vascular resistance and reducing water and sodium retention by inhibiting aldosterone secretion. This product can also dilate peripheral blood vessels by interfering with the degradation of bradykinin. For patients with heart failure, this product can also reduce capillary wedge pressure and pulmonary vascular resistance, increase cardiac output and exercise tolerance time. |
62571-86-2 | 28 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Acyclovir |
This product is an antiviral drug. It has an inhibitory effect on herpes simplex virus, varicella zoster virus, cytomegalovirus, etc. in vitro. After entering the cells infected by herpes virus, this product competes with deoxynucleoside for viral thymidine kinase or cell kinase, and the drug is phosphorylated into activated acyclovir triphosphate, and then inhibits viral replication in two ways: ① Interfering with viral DNA polymerase and inhibiting viral replication; ② Under the action of DNA polymerase, it binds to the growing DNA chain, causing the extension of the DNA chain to be interrupted. This product has a special affinity for viruses, but has low toxicity to mammalian host cells.
More
This product is an antiviral drug. It has an inhibitory effect on herpes simplex virus, varicella zoster virus, cytomegalovirus, etc. in vitro. After entering the cells infected by herpes virus, this product competes with deoxynucleoside for viral thymidine kinase or cell kinase, and the drug is phosphorylated into activated acyclovir triphosphate, and then inhibits viral replication in two ways: ① Interfering with viral DNA polymerase and inhibiting viral replication; ② Under the action of DNA polymerase, it binds to the growing DNA chain, causing the extension of the DNA chain to be interrupted. This product has a special affinity for viruses, but has low toxicity to mammalian host cells. |
59277-89-3 | 50 |